Elafibranor is a dual PPARalpha/delta agonist (EC50 PPARalpha = 10-20 nM, PPARdelta = 100-150 nM).1 It was able to decrease plasma triglycerides levels1, increase HDL cholesterol levels in human studies1, and improve hepatic and peripheral insulin sensit
* VAT and and shipping costs not included. Errors and price changes excepted
